"10.1371_journal.pone.0001779","plos one","2008-03-05T00:00:00Z","Daniel G Wootton; Hyginus Opara; Giancarlo A Biagini; Maxwell K Kanjala; Stephan Duparc; Paula L Kirby; Mary Woessner; Colin Neate; Maggie Nyirenda; Hannah Blencowe; Queen Dube-Mbeye; Thomas Kanyok; Stephen Ward; Malcolm Molyneux; Sam Dunyo; Peter A Winstanley","Department of Pharmacology & Therapeutics, University of Liverpool, Liverpool, United Kingdom; Malawi-Liverpool-Wellcome Trust Major Overseas Programme, College of Medicine, Blantyre, Malawi; MRC Laboratories, Banjul, Fajara, The Gambia; Liverpool School of Tropical Medicine, Liverpool, United Kingdom; GlaxoSmithKline, Greenford, Middlesex, United Kingdom; Department of Paediatrics, College of Medicine, Blantyre, Malawi; Global Health-Infectious Diseases, Bill and Melinda Gates Foundation, Seattle, Washington, United States of America (formerly at the WHO-UNDP-World Bank Special Programme for Research and Training in Tropical Medicine (WHO-TDR), Geneva, Switzerland)","Conceived and designed the experiments: MM SW PW GB SD PK MW CN TK. Performed the experiments: SD MK DW HO GB MN HB QD. Analyzed the data: MW CN. Wrote the paper: SD MM MK SW PW DW HO GB SD PK MW CN MN HB QD TK. Other: Developed the parasite viability assay protocol: GB SW. Managed the clinical trial: SD PK.","Paula Kirby and Mary Woessner are current employees of GlaxoSmithKline, and Stephan Duparc and Colin Neate are former employees of GlaxoSmithKline.","2008","03","Daniel G Wootton","DGW",16,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
